Cargando…
Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model
Oxaliplatin, fluorouracil plus leucovorin (FOLFOX) regimen is the first-line chemotherapy of patients with metastatic colorectal cancer (mCRC). However, studies are limited regarding long non-coding RNAs (lncRNAs) associated with FOLFOX chemotherapy response and prognosis. This study aimed to identi...
Autores principales: | Zhang, Yiyi, Xu, Meifang, Sun, Yanwu, Chen, Ying, Chi, Pan, Xu, Zongbin, Lu, Xingrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876414/ https://www.ncbi.nlm.nih.gov/pubmed/33585448 http://dx.doi.org/10.3389/fcell.2020.609832 |
Ejemplares similares
-
FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis
por: Zhang, Yiyi, et al.
Publicado: (2020) -
Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021) -
LncPep: A Resource of Translational Evidences for lncRNAs
por: Liu, Teng, et al.
Publicado: (2022) -
The role of lncRNAs and XIST in oral cancer
por: Liu, Huimin, et al.
Publicado: (2022) -
The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer
por: Xu, Yan, et al.
Publicado: (2023)